4/A//SEC Filing
Allison David D. 4/A
Accession 0001209191-22-042696
CIK 0001868734other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:39 PM ET
Size
5.7 KB
Accession
0001209191-22-042696
Insider Transaction Report
Form 4/AAmended
Allison David D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-04-08$12.04/sh+1,038$12,498→ 1,038 totalExercise: $19.55From: 2022-04-08Exp: 2032-04-07→ Common Stock (1,038 underlying)
Footnotes (2)
- [F1]This option was issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of retainer fees of $12,500.
- [F2]This amendment to the Form 4 initially filed on May 11, 2022 is being made to clarify the purpose of the option grant set forth in footnote 1 above and the amount in director retainer fees foregone as set forth in box 8 above.
Documents
Issuer
CinCor Pharma, Inc.
CIK 0001868734
Entity typeother
Related Parties
1- filerCIK 0001853903
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:39 PM ET
- Size
- 5.7 KB